Salipro Biotech announces a new research collaboration

Salipro Biotech has entered into a new research collaboration agreement with a Next-Generation Biotech company in the USA. Within this new collaboration, the Salipro® platform will be used in combination with the company's Machine Learning platform to develop drug candidates against a GPCR target.

We look forward to the advancements that this collaboration will bring in our commitment to make the undruggable druggable!